Zomedica Q1 2024 GAAP EPS $(0.01) Down From $(0.01) YoY, Sales $6.262M Miss $8.184M Estimate
Zomedica Q1 2024 GAAP EPS $(0.01) Down From $(0.01) YoY, Sales $6.262M Miss $8.184M Estimate
Zomedica 2024年第一季度GAAP每股收益爲0.01美元，低於同比0.01美元，銷售額爲626.2萬美元，低於預期的818.4萬美元
Zomedica (AMEX:ZOM) reported quarterly losses of $(0.01) per share. This is a 42.86 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $6.262 million which missed the analyst consensus estimate of $8.184 million by 23.48 percent. This is a 14.23 percent increase over sales of $5.482 million the same period last year.
Zomedica（美國證券交易所股票代碼：ZOM）報告稱，季度每股虧損爲0.01美元。與去年同期每股虧損0.01美元（0.01）相比，下降了42.86％。該公司公佈的季度銷售額爲626.2萬美元，比分析師普遍預期的818.4萬美元低23.48％。這比去年同期的548.2萬美元的銷售額增長了14.23％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。